USD
$0.00
(0.00%
)At Close (As of Sep 12, 2025)
$54.27M
Market Cap
-
P/E Ratio
-0.43
EPS
$5.12
52 Week High
$1.28
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $11M |
Total Revenue | $24M |
Cost Of Revenue | $14M |
Costof Goods And Services Sold | $14M |
Operating Income | -$36M |
Selling General And Administrative | $19M |
Research And Development | $3.8M |
Operating Expenses | $46M |
Investment Income Net | - |
Net Interest Income | -$4.8M |
Interest Income | - |
Interest Expense | $4.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $3.5M |
Income Before Tax | -$54M |
Income Tax Expense | $7K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$54M |
Comprehensive Income Net Of Tax | - |
Ebit | -$49M |
Ebitda | -$46M |
Net Income | -$54M |
Field | Value (USD) |
---|---|
Total Assets | $36M |
Total Current Assets | $26M |
Cash And Cash Equivalents At Carrying Value | $13M |
Cash And Short Term Investments | $13M |
Inventory | $3.9M |
Current Net Receivables | $7M |
Total Non Current Assets | $10M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $8.3M |
Intangible Assets Excluding Goodwill | $8.3M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2M |
Other Non Current Assets | - |
Total Liabilities | $82M |
Total Current Liabilities | $38M |
Current Accounts Payable | $4.1M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.7M |
Total Non Current Liabilities | $45M |
Capital Lease Obligations | $883K |
Long Term Debt | $23M |
Current Long Term Debt | $1.3M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $25M |
Other Current Liabilities | $32M |
Other Non Current Liabilities | $5.5M |
Total Shareholder Equity | -$46M |
Treasury Stock | - |
Retained Earnings | -$230M |
Common Stock | $35K |
Common Stock Shares Outstanding | $29M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$23M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $3.5M |
Capital Expenditures | $654K |
Change In Receivables | - |
Change In Inventory | -$58K |
Profit Loss | - |
Cashflow From Investment | -$474K |
Cashflow From Financing | $17M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$54M |
Field | Value (USD) |
---|---|
Gross Profit | $11M |
Total Revenue | $24M |
Cost Of Revenue | $14M |
Costof Goods And Services Sold | $14M |
Operating Income | -$36M |
Selling General And Administrative | $19M |
Research And Development | $3.8M |
Operating Expenses | $46M |
Investment Income Net | - |
Net Interest Income | -$4.8M |
Interest Income | - |
Interest Expense | $4.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $3.5M |
Income Before Tax | -$54M |
Income Tax Expense | $7K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$54M |
Comprehensive Income Net Of Tax | - |
Ebit | -$49M |
Ebitda | -$46M |
Net Income | -$54M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.